Paper Details

  1. Home
  2. Paper Details

New strategies for patenting biological medicines used in rheumatoid arthritis treatment.

Author: FierroIolanda M, OliveiraRodrigo Ayres de

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Rheumatoid arthritis (RA) is a chronic autoimmune disease with a global prevalence of 0.3% to 1%. Current RA treatment strategies involve aggressive and stepped therapies, but new drugs are needed to overcome limitations of existing treatments.
Paper Details　
Original Abstract of the Article :
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by an inflammatory process, with a global prevalence ranging from 0.3% to 1%. The overall cost of RA drugs is estimated in $20 billion worldwide and projected to grow to $36 billion by 2021. The current RA treatment strategy con...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/13543776.2018.1502748

データ提供：米国国立医学図書館（NLM）

New Strategies for Patenting Biological Medicines Used in Rheumatoid Arthritis Treatment

This study explores the development of new biological medicines for treating rheumatoid arthritis, a chronic autoimmune disease characterized by inflammation in the joints. Imagine the desert as a battlefield, where the immune system, like a rogue army, attacks the body's own tissues, causing pain and inflammation. This study, like a team of pharmaceutical researchers, is seeking new weapons to combat this relentless disease.

New Biological Medicines: A Promising Frontier in Rheumatoid Arthritis Treatment

The study highlights the need for new antirheumatic drugs to overcome the limitations of existing treatments, such as conventional drugs and biological therapies. These new medicines, like powerful allies in the battlefield, are being developed to offer more effective and targeted treatments for rheumatoid arthritis, with fewer side effects. The study also discusses the importance of patent protection for these new medicines, ensuring that they can be developed and made available to patients.

A Oasis of Hope for Rheumatoid Arthritis: New Medications on the Horizon

This research offers hope for patients struggling with rheumatoid arthritis. The development of new biological medicines, like finding a well-stocked oasis in the desert of chronic inflammation, could lead to more effective and targeted treatments, potentially improving quality of life for many individuals.

Dr.Camel's Conclusion

This study underscores the ongoing efforts to develop new biological medicines for treating rheumatoid arthritis. It's like a caravan traveling through the desert, carrying the promise of a better future for those battling this debilitating disease.

Date :
  1. Date Completed 2018-08-30
  2. Date Revised 2019-02-22
Further Info :

Pubmed ID

30047807

DOI: Digital Object Identifier

10.1080/13543776.2018.1502748

Related Literature

Article Analysis
・Side Effects of sulfasalazine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.